In terms of principles, of getting the best bang for your buck for your investment, I wouldn't turn to a nation. I'd look at something like Kaiser. Kaiser manages in such a way as to get the best bang for their buck. If you can emulate their principles in a national pharmacare program, I think you would be in great shape.
On May 30th, 2016. See this statement in context.